BioPharma

13 May, 2026 | Wednesday | News

Curocell And ProBio Achieve Korean Milestone With Approval Of Next Generation CAR T Therapy Anbal cel

Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene therapies, ProBio Inc. and Curocell have achieved a signi...

Lab

14 May, 2026 | Thursday | News

Isomorphic Labs Raises $2.1 Billion To Scale AI Driven Drug Discovery Platform

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and develop...

BioTech

14 May, 2026 | Thursday | News

GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a ne...

Contract Services

06 May, 2026 | Wednesday | News

VectorBuilder Secures European Patent For MiniVec Plasmid System Advancing Genetic Medicine Development

Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines  VectorBuilder, a global leader in gene delivery technologies and CDMO services,  ann...

Consumer Health

11 May, 2026 | Monday | News

Redefining Hearing Care Through Personalised Sound Preference Across APAC

As hearing care evolves beyond conventional amplification models, personalisation is emerging as a critical factor in improving patient outcomes and long term device adoption. In this exclusiv...

Medtech

05 May, 2026 | Tuesday | News

Olympus Corporation Partners With EndoRobotics To Advance Global Access To Robot Assisted Endoscopic Care

Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic Procedures  Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced ...

Cell & Gene

13 May, 2026 | Wednesday | News

Porton Advanced And Dark Horse Consulting Group Form Strategic Alliance To Accelerate Global Cell And Gene Therapy Translation

Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products (ATMPs), and Dark Horse Consulting Group ("DHCG" or "the Group"), a lead...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close